Home > Insider Trading > Filing (0001209191-14-003437)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1571498	Epizyme Inc.	EPZM	Pharmaceutical Preparations (2834)	261349956

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1577021	A Robert Copeland	C/O Epizyme, Inc. 400 Technology Square Cambridge MA 02139	Evp And Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-01-13	5,596	$38.86	47,948	No	4	S	Direct
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-01-13	3,858	$39.86	44,090	No	4	S	Direct
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-01-13	3,286	$38.86	28,197	No	4	S	Indirect	By Wife
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-01-13	2,266	$39.86	25,931	No	4	S	Indirect	By Wife

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By Wife
No	4	S	Indirect	By Wife

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2013.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.40 per share to $39.38 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, fully information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.49 per share to $40.38 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, fully information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.